Kidney Diseases  >>  cyclosporine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00273871: Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

Completed
3
190
Europe
Cyclosporin or tacrolimus
Wyeth is now a wholly owned subsidiary of Pfizer
Graft Rejection, Kidney Failure, Kidney Transplantation
 
09/06
NCT00167947: Study Evaluating Sirolimus in Kidney Transplant Recipients.

Completed
3
150
Europe
Cyclosporine, Steroids, Rapamune (Sirolimus)
Wyeth is now a wholly owned subsidiary of Pfizer
Kidney Failure, Graft vs Host Disease
07/07
07/07
NCT00248313: Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Completed
3
470
RoW
Rapamune®
Wyeth is now a wholly owned subsidiary of Pfizer
Kidney Disease
 
10/07
NCT00309218: Steroid Withdrawal in Pediatric Renal Transplant Recipients Under Cyclosporine (CyA) and Mycophenolate Mofetil (MMF)

Completed
3
42
Europe
methylprednisolone
Klinik für Kinder- und Jugendmedizin, Hoffmann-La Roche
Kidney Diseases
06/08
06/08
BENEFIT, NCT00256750 / 2004-003635-31: Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression

Checkmark ESOT 2015
Aug 2015 - Aug 2015: ESOT 2015
Checkmark ESOT 2015
Aug 2015 - Aug 2015: ESOT 2015
Checkmark ESOT 2015
More
Completed
3
738
US, Canada, Europe, RoW
Cyclosporine (CsA), Belatacept LI (less intensive), Belatacept MI (more intensive)
Bristol-Myers Squibb
Kidney Transplantation, Chronic Kidney Failure
06/08
04/15

Download Options